Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non-Small-Cell Lung Cancer
Reck M, Piault E, Lee A, Kelsch C, Patel H, Shankar G, Coleman S, Deng Y, Yu W, Früh M, Rothenstein J, González Larriba J, Shtivelband M, Moro-Sibilot D, Barone C, Nogami N, Orlandi F, Wehler T, Socinski M. Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non-Small-Cell Lung Cancer. J Clin Oncol 2020; 38:2530-2542.
27.05.2020
Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non-Small-Cell Lung Cancer
27.05.2020
J Clin Oncol 2020; 38:2530-2542
Reck Martin, Piault Elisabeth, Lee Anthony, Kelsch Claudia, Patel Hina, Shankar Geetha, Coleman Shelley, Deng Yu, Yu Wei, Früh Martin, Rothenstein Jeffrey, González Larriba Jose Luis, Shtivelband Mikhail, Moro-Sibilot Denis, Barone Carlo, Nogami Naoyuki, Orlandi Francisco, Wehler Thomas, Socinski Mark A
Weiter
